Patents Assigned to Merck Patents GmbH
  • Device containing a liquid-crystalline medium
    Patent number: 10301545
    Abstract: The present invention relates to a temperature-reactive device for the regulation of light transmission, containing a liquid-crystalline medium and a compound of formula I, capable of promoting or inducing homeotropic alignment to the adjacent liquid crystal medium at a given temperature. The invention furthermore relates to a process for the temperature-dependent control of light transmission through a layer of a liquid-crystalline medium.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: May 28, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Graziano Archetti, Andreas Taugerbeck
  • Liquid-crystal medium
    Patent number: 10301544
    Abstract: A liquid-crystalline medium, in particular based on a mixture of polar compounds, having compounds of formulae Y, CY, PY and/or LY, and compounds of formula S1 and/or S2:
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: May 28, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Gavin Hung, Lawrence Huang, Max Nien
  • Glycosidase inhibitors
    Patent number: 10301299
    Abstract: Compounds of formula (I) wherein X1, X2, W, R1 to R5, L and m have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: May 28, 2019
    Assignee: Merck Patent GmbH
    Inventors: Henry Yu, Lesley Liu-Bujalski, Theresa L. Johnson
  • LIQUID CRYSTALLINE MEDIUM
    Publication number: 20190153320
    Abstract: The present invention relates to liquid crystalline media comprising one or more benzothiadiazol derivatives of formula I, in which R11, R12, A11, A12, A21, A22, Z11, Z12, Z21, Z22, W, X11, X12, r and s have the meanings indicated in claim 1, to the use of such liquid crystal media for optical, electro-optical and electronic purposes, in particular in devices for regulating the passage of energy from an outside space into an inside space, for example in windows.
    Type: Application
    Filed: July 17, 2017
    Publication date: May 23, 2019
    Applicant: Merck Patent GmbH
    Inventors: Peer KIRSCH, Andreas RUHL, Michael JUNGE, Ursula PATWAL, Mila FISCHER
  • DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES
    Publication number: 20190157578
    Abstract: The present invention relates to bi- and oligonuclear metal complexes and to electronic devices, especially organic electroluminescent devices, comprising these metal complexes.
    Type: Application
    Filed: July 20, 2017
    Publication date: May 23, 2019
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich
  • DIAZIRINE CONTAINING ORGANIC ELECTRONIC COMPOSITIONS AND DEVICE THEREOF
    Publication number: 20190157558
    Abstract: The present invention relates to organic electronic devices, and more specifically to organic field effect transistors, comprising a dielectric layer that comprises a polycycloolefinic polymer and a diazirine compound.
    Type: Application
    Filed: January 25, 2019
    Publication date: May 23, 2019
    Applicants: PROMERUS, LLC, MERCK PATENT GMBH
    Inventors: LARRY F RHODES, HUGH BURGOON, IRINA AFONINA, TOMAS BACKLUND, AURELIE MORLEY
  • METHOD FOR THE PRODUCTION OF SINGLE CRYSTALLINE TIO2 FLAKES
    Publication number: 20190153613
    Abstract: The present invention is related to a method for the production of single crystalline TiO2 flakes in the rutile crystal structure, to single crystalline TiO2 flakes obtained by this method as well as to the use thereof, especially as pigments in several application media.
    Type: Application
    Filed: January 22, 2019
    Publication date: May 23, 2019
    Applicant: Merck Patent GmbH
    Inventor: Ryuta SUZUKI
  • A COLOR CONVERSION SHEET AND AN OPTICAL DEVICE
    Publication number: 20190153307
    Abstract: The present invention relates to a color conversion sheet (100) and an optical device comprising a color conversion sheet (100). The present invention further relates to a use of the color conversion sheet (100) in an optical device (200). The invention further more relates to method for preparing the color conversion sheet (100) and method for preparing the optical device (200).
    Type: Application
    Filed: March 29, 2017
    Publication date: May 23, 2019
    Applicants: Merck Patent GmbH, AZ Electronic Materials (Luxembourg) S.A.R.L.
    Inventors: Bernhard RIEGER, Christian MATUSCHEK, Ralf GROTTENMUELLER
  • Substituted boronic acids and boronate esters as immunoproteasome inhibitors
    Patent number: 10294246
    Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: May 21, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Markus Klein, Oliver Schadt, Philipp Haselmayer, Michael Busch
  • Liquid crystalline media having homeotropic alignment
    Patent number: 10294426
    Abstract: The present invention relates to liquid-crystalline media (LC media) having negative or positive dielectric anisotropy, comprising a low-molecular-weight component and a polymerizable component. The polymerizable component comprises self-aligning, polymerizable mesogens (polymerizable self-alignment additives) which effect homeotropic (vertical) alignment of the LC media at a surface or the cell walls of a liquid-crystal display (LC display). The invention therefore also encompasses LC displays having homeotropic alignment of the LC medium without alignment layers. The invention discloses novel structures for polymerizable self-alignment additives which have a certain position of the functional groups.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: May 21, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Graziano Archetti, Izumi Saito, Rocco Fortte, Oliver Heppert, Andreas Taugerbeck, Elena Neumann
  • PD-1/PD-L1 Inhibitors for Cancer Treatment
    Publication number: 20190144545
    Abstract: The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1.
    Type: Application
    Filed: May 22, 2017
    Publication date: May 16, 2019
    Applicants: MERCK PATENT GMBH, PFIZER INC.
    Inventors: Dimitry NUYTEN, Alexei MOROZOV, Adrian WOOLFSON, Aron THALL, Kevin CHIN, Satjit BRAR
  • Organic Dielectric Layer and Organic Electronic Device
    Publication number: 20190148657
    Abstract: The present invention relates to organic dielectric layers comprising a polycycloolefinic polymer with a pendent chromophoric group having an absorption maximum in the wavelength range from 230 to 290 nm, and to organic electronic devices comprising them.
    Type: Application
    Filed: May 15, 2017
    Publication date: May 16, 2019
    Applicants: PROMERUS, LLC, MERCK PATENT GMBH
    Inventors: IRINA AFONINA, TOMAS BACKLUND, LARRY F RHODES, HUGH A BURGOON
  • ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF FIBROSIS AND/OR FIBROTIC DISORDERS
    Publication number: 20190144547
    Abstract: A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-?v integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.
    Type: Application
    Filed: November 22, 2016
    Publication date: May 16, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Ilhan CELIK, Eike STAUB, Miriam URBAN, Sabine RAAB, Eileen SAMY, Andrew BENDER, Georgianna HIGGINBOTHAM, Yin WU, Daigen XU
  • Heterocyclic derivatives as modulators of kinase activity
    Patent number: 10287300
    Abstract: The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 14, 2019
    Assignee: Merck Patent GmbH
    Inventors: Ruoxi Lan, Bayard R. Huck, Xiaoling Chen, Yufang Xiao
  • Laser-markable and laser-weldable polymeric materials
    Patent number: 10286706
    Abstract: The present invention relates to laser-markable and laser-weldable polymeric materials which are distinguished by the fact that they comprise, as laser absorber, at least one copper-doped zinc sulfide.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: May 14, 2019
    Assignee: Merck Patent GmbH
    Inventors: Reinhold Rueger, Ulrich Quittmann, Silvia Rosenberger
  • Metal complexes
    Patent number: 10290819
    Abstract: The present invention relates to bisimidazolium salts, to novel mono- and biscarbenes derived therefrom, and to metal complexes which contain corresponding mono- and biscarbenes as ligands, to a process for the preparation of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the metal complexes according to the invention, and to the use of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the use of the metal complexes according to the invention.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: May 14, 2019
    Assignee: Merck Patent GmbH
    Inventors: Doris Kunz, Verena Gierz
  • PIPERIDINYL DERIVATIVES
    Publication number: 20190135753
    Abstract: Compounds of the formula I in which X, Y, R1 and R2 have the meanings indicated in claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
    Type: Application
    Filed: April 25, 2017
    Publication date: May 9, 2019
    Applicant: MERCK PATENT GMBH
    Inventor: Hans-Peter BUCHSTALLER
  • USE OF AN AMINO SUGAR AS PLASTICIZER
    Publication number: 20190134200
    Abstract: The present invention relates to the use of an amino sugar as plasticizer in formulations comprising a polymer as carrier for active ingredients, in particular for compositions which are intensively mixed by treatment in a melt extrusion and then formulated by suitable post-treatment.
    Type: Application
    Filed: May 10, 2017
    Publication date: May 9, 2019
    Applicant: Merck Patent GmbH
    Inventors: Dieter LUBDA, Mengyao ZHENG, Alessandro ELIA, Nicole DI GALLO, Anja-Nadine KNUETTEL
  • MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
    Publication number: 20190135814
    Abstract: The present invention relates to compounds of formula (1). The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds.
    Type: Application
    Filed: April 26, 2017
    Publication date: May 9, 2019
    Applicant: Merck Patent GmbH
    Inventors: Amir PARHAM, Tobias GROSSMANN, Jonas KROEBER
  • Compositions containing cyclic peptides and methods of use
    Patent number: 10278911
    Abstract: The invention relates generally to cyclic peptides and their use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said cyclic peptides.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 7, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Soheila Anzali, Alfred Jonczyk